Welcome To The Resverlogix HUB On AGORACOM

**Apabetalone (RVX-208) Currently Being Tested in a Phase 3 BETonMACE Trial and a Phase 2 Kidney Trial is Planned for 2017**

Free
AGORACOM NEWS FLASH

NEW CLIENT ALERT!!!

AGORACOM Welcomes BetterU Education Corp. (TSX-V:BTRU)

  • Connecting global education with the Indian Marketplace
  • $30 million marketing investment deal signed
  • Ability to reach 100 MILLION potential learners each week
  • India expecting to double in online education sales from $20B to $40B this year

CHECK OUT OUR RECENT INTERVIEW!

Betteru large

Hub On AGORACOM / Corporate Profile

Message: A few comments

Interesting summary tada, my estimations have come out somewhat similar to yours (not quite as high on the high end) and the company's own NPV chart would suggest the correct neighbourhood (even more when you repeat the exercise for CKD). In any event thanks.  I revisited clinical trials.gov which I was led to believe were outside dates and it says final data collection for primary outcome is sept 2018 so I guess we'll know when we know. 

Share
New Message
Please login to post a reply